GlassScriptPhysician profile
Georgia Miller
NPI 1467935288
$4,211.62
in general payments reported to CMS, 2019-2025
46 companies · $935 in 2025
The $935 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,871 · 2022: $835 · 2023: $239 · 2024: $330 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,376 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,376.01 |
| Education | $128.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $630.39 | 2021-2024 | Myrbetriq |
| Coloplast Corp | $562.49 | 2021-2022 | |
| Pfizer INC. | $288.72 | 2021-2025 | |
| Antares Pharma, INC. | $217.40 | 2021-2024 | Xyosted |
| Abbvie INC. | $162.98 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $149.64 | 2023-2025 | Gemtesa, Orgovyx |
| Novo Nordisk INC | $141.90 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Biotech, INC. | $139.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.64 | 2021-2025 | |
| Lilly USA, LLC | $128.10 | 2025 | Mounjaro, Zepbound, Jardiance |
| Teleflex LLC | $123.28 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $123.07 | 2021-2023 | Aveed, Xiaflex |
| Boston Scientific Corporation | $105.41 | 2022-2025 | Rezum Generator, Wavewriter Alpha Prime 16 |
| Urovant Sciences INC | $101.16 | 2021-2022 | |
| Clarus Therapeutics INC. | $97.12 | 2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgia Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.